Loading…

Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae

Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium (VcCA) presents an alternative therapeutic target. In this s...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2020-04, Vol.21 (9), p.3131
Main Authors: Demir-Yazıcı, Kübra, Güzel-Akdemir, Özlen, Angeli, Andrea, Supuran, Claudiu T, Akdemir, Atilla
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443
cites cdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443
container_end_page
container_issue 9
container_start_page 3131
container_title International journal of molecular sciences
container_volume 21
creator Demir-Yazıcı, Kübra
Güzel-Akdemir, Özlen
Angeli, Andrea
Supuran, Claudiu T
Akdemir, Atilla
description Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium (VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1 -indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.
doi_str_mv 10.3390/ijms21093131
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7247680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2398642396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</originalsourceid><addsrcrecordid>eNpdkctu1TAURS1ERUthxhhZYtJBA34kTjxBaq9KW6mCDoCp5cdx46skLnZSqUz4Jn6Eb6ovfejC5PhIe3nbWxuhN5S851ySD2E9ZkaJ5JTTZ2iP1oxVhIj2-da-i17mvCaEcdbIF2iXMy6aumN76NfneAMDPp9cHKA61hkcPrt1Sf-ME2SsM76MM0xzIfpgwhxTxtHjuQf853dlB50zXulk4hQsPpr6zdUM2Kc44ks99_EKNsqxtjOksIz4ezApRGz78l7S8ArteD1keP1w7qNvn06-rs6qiy-n56uji8rWlM2V7ljrCWPeNrRlsnFONrqTDqiXvvWcA9GMCiI7YIQZQ5wR3nRGdrUUrq75Pvp473u9mBGcLZGSHtR1CqNOtyrqoP5VptCrq3ijWla3oiPF4ODBIMUfC-RZjSFbGAY9QVyyYlx2oi5TFPTdf-g6Lmkq8f5SRDAp20Id3lM2xZwT-KfPUKI2zartZgv-djvAE_xYJb8Dopmhjw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2398062997</pqid></control><display><type>article</type><title>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Demir-Yazıcı, Kübra ; Güzel-Akdemir, Özlen ; Angeli, Andrea ; Supuran, Claudiu T ; Akdemir, Atilla</creator><creatorcontrib>Demir-Yazıcı, Kübra ; Güzel-Akdemir, Özlen ; Angeli, Andrea ; Supuran, Claudiu T ; Akdemir, Atilla</creatorcontrib><description>Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium (VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1 -indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21093131</identifier><identifier>PMID: 32365482</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amino Acid Sequence ; Amino acids ; Antibiotics ; Antimicrobial agents ; Bacteria ; Binding Sites ; Carbonic anhydrase ; Carbonic Anhydrase Inhibitors - chemistry ; Carbonic Anhydrase Inhibitors - pharmacology ; Cholera ; Crystal structure ; Drug development ; Enzyme Activation ; Enzymes ; Epidemics ; Gene expression ; Hydrazones ; Hydrazones - chemistry ; Hydrogen bonds ; Indoles ; Indoles - chemistry ; Inhibitors ; Ligands ; Molecular Conformation ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Molecular modelling ; Molecular Structure ; Protein Binding ; Selectivity ; Simulation ; Structure-Activity Relationship ; Sulfonamides ; Therapeutic applications ; Vibrio cholerae ; Vibrio cholerae - drug effects ; Vibrio cholerae - enzymology</subject><ispartof>International journal of molecular sciences, 2020-04, Vol.21 (9), p.3131</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</citedby><cites>FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</cites><orcidid>0000-0001-9928-4733 ; 0000-0003-3680-1945 ; 0000-0003-4262-0323 ; 0000-0002-1470-7192 ; 0000-0001-8416-0471</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2398062997/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2398062997?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,75096</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32365482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Demir-Yazıcı, Kübra</creatorcontrib><creatorcontrib>Güzel-Akdemir, Özlen</creatorcontrib><creatorcontrib>Angeli, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><creatorcontrib>Akdemir, Atilla</creatorcontrib><title>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium (VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1 -indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.</description><subject>Amino Acid Sequence</subject><subject>Amino acids</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Binding Sites</subject><subject>Carbonic anhydrase</subject><subject>Carbonic Anhydrase Inhibitors - chemistry</subject><subject>Carbonic Anhydrase Inhibitors - pharmacology</subject><subject>Cholera</subject><subject>Crystal structure</subject><subject>Drug development</subject><subject>Enzyme Activation</subject><subject>Enzymes</subject><subject>Epidemics</subject><subject>Gene expression</subject><subject>Hydrazones</subject><subject>Hydrazones - chemistry</subject><subject>Hydrogen bonds</subject><subject>Indoles</subject><subject>Indoles - chemistry</subject><subject>Inhibitors</subject><subject>Ligands</subject><subject>Molecular Conformation</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Dynamics Simulation</subject><subject>Molecular modelling</subject><subject>Molecular Structure</subject><subject>Protein Binding</subject><subject>Selectivity</subject><subject>Simulation</subject><subject>Structure-Activity Relationship</subject><subject>Sulfonamides</subject><subject>Therapeutic applications</subject><subject>Vibrio cholerae</subject><subject>Vibrio cholerae - drug effects</subject><subject>Vibrio cholerae - enzymology</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkctu1TAURS1ERUthxhhZYtJBA34kTjxBaq9KW6mCDoCp5cdx46skLnZSqUz4Jn6Eb6ovfejC5PhIe3nbWxuhN5S851ySD2E9ZkaJ5JTTZ2iP1oxVhIj2-da-i17mvCaEcdbIF2iXMy6aumN76NfneAMDPp9cHKA61hkcPrt1Sf-ME2SsM76MM0xzIfpgwhxTxtHjuQf853dlB50zXulk4hQsPpr6zdUM2Kc44ks99_EKNsqxtjOksIz4ezApRGz78l7S8ArteD1keP1w7qNvn06-rs6qiy-n56uji8rWlM2V7ljrCWPeNrRlsnFONrqTDqiXvvWcA9GMCiI7YIQZQ5wR3nRGdrUUrq75Pvp473u9mBGcLZGSHtR1CqNOtyrqoP5VptCrq3ijWla3oiPF4ODBIMUfC-RZjSFbGAY9QVyyYlx2oi5TFPTdf-g6Lmkq8f5SRDAp20Id3lM2xZwT-KfPUKI2zartZgv-djvAE_xYJb8Dopmhjw</recordid><startdate>20200429</startdate><enddate>20200429</enddate><creator>Demir-Yazıcı, Kübra</creator><creator>Güzel-Akdemir, Özlen</creator><creator>Angeli, Andrea</creator><creator>Supuran, Claudiu T</creator><creator>Akdemir, Atilla</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9928-4733</orcidid><orcidid>https://orcid.org/0000-0003-3680-1945</orcidid><orcidid>https://orcid.org/0000-0003-4262-0323</orcidid><orcidid>https://orcid.org/0000-0002-1470-7192</orcidid><orcidid>https://orcid.org/0000-0001-8416-0471</orcidid></search><sort><creationdate>20200429</creationdate><title>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</title><author>Demir-Yazıcı, Kübra ; Güzel-Akdemir, Özlen ; Angeli, Andrea ; Supuran, Claudiu T ; Akdemir, Atilla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amino Acid Sequence</topic><topic>Amino acids</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Binding Sites</topic><topic>Carbonic anhydrase</topic><topic>Carbonic Anhydrase Inhibitors - chemistry</topic><topic>Carbonic Anhydrase Inhibitors - pharmacology</topic><topic>Cholera</topic><topic>Crystal structure</topic><topic>Drug development</topic><topic>Enzyme Activation</topic><topic>Enzymes</topic><topic>Epidemics</topic><topic>Gene expression</topic><topic>Hydrazones</topic><topic>Hydrazones - chemistry</topic><topic>Hydrogen bonds</topic><topic>Indoles</topic><topic>Indoles - chemistry</topic><topic>Inhibitors</topic><topic>Ligands</topic><topic>Molecular Conformation</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Dynamics Simulation</topic><topic>Molecular modelling</topic><topic>Molecular Structure</topic><topic>Protein Binding</topic><topic>Selectivity</topic><topic>Simulation</topic><topic>Structure-Activity Relationship</topic><topic>Sulfonamides</topic><topic>Therapeutic applications</topic><topic>Vibrio cholerae</topic><topic>Vibrio cholerae - drug effects</topic><topic>Vibrio cholerae - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Demir-Yazıcı, Kübra</creatorcontrib><creatorcontrib>Güzel-Akdemir, Özlen</creatorcontrib><creatorcontrib>Angeli, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><creatorcontrib>Akdemir, Atilla</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Demir-Yazıcı, Kübra</au><au>Güzel-Akdemir, Özlen</au><au>Angeli, Andrea</au><au>Supuran, Claudiu T</au><au>Akdemir, Atilla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-04-29</date><risdate>2020</risdate><volume>21</volume><issue>9</issue><spage>3131</spage><pages>3131-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium (VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1 -indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32365482</pmid><doi>10.3390/ijms21093131</doi><orcidid>https://orcid.org/0000-0001-9928-4733</orcidid><orcidid>https://orcid.org/0000-0003-3680-1945</orcidid><orcidid>https://orcid.org/0000-0003-4262-0323</orcidid><orcidid>https://orcid.org/0000-0002-1470-7192</orcidid><orcidid>https://orcid.org/0000-0001-8416-0471</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2020-04, Vol.21 (9), p.3131
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7247680
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Amino Acid Sequence
Amino acids
Antibiotics
Antimicrobial agents
Bacteria
Binding Sites
Carbonic anhydrase
Carbonic Anhydrase Inhibitors - chemistry
Carbonic Anhydrase Inhibitors - pharmacology
Cholera
Crystal structure
Drug development
Enzyme Activation
Enzymes
Epidemics
Gene expression
Hydrazones
Hydrazones - chemistry
Hydrogen bonds
Indoles
Indoles - chemistry
Inhibitors
Ligands
Molecular Conformation
Molecular Docking Simulation
Molecular Dynamics Simulation
Molecular modelling
Molecular Structure
Protein Binding
Selectivity
Simulation
Structure-Activity Relationship
Sulfonamides
Therapeutic applications
Vibrio cholerae
Vibrio cholerae - drug effects
Vibrio cholerae - enzymology
title Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T13%3A22%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Indole-Based%20Hydrazones%20as%20Potent%20Inhibitors%20of%20the%20%CE%B1-class%20Carbonic%20Anhydrase%20from%20Pathogenic%20Bacterium%20Vibrio%20cholerae&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Demir-Yaz%C4%B1c%C4%B1,%20K%C3%BCbra&rft.date=2020-04-29&rft.volume=21&rft.issue=9&rft.spage=3131&rft.pages=3131-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21093131&rft_dat=%3Cproquest_pubme%3E2398642396%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-a827f022fc517295dd95a89de1f9f7f33e0a216098e202bb0db6fb8b98496d443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2398062997&rft_id=info:pmid/32365482&rfr_iscdi=true